| abstract |
Disclosed is a composition comprising propylsulfamic acid [5-(bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2yloxy)-ethoxy]-pyrimidin-4-yl]-amide or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof, lactose monohydrate with microcrystalline cellulose, sodium starch glycolate or a combination of sodium starch glycolate and polyvinylpyrrolidone, a surfactant, consisting of a polysorbate and magnesium stearate. Also disclosed is the use of said composition in the treatment of hypertension. |